Most people with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD) report that therapeutic approaches, including medications and other therapies, do not help ease their muscle and joint pain. Indeed, fewer than 30% of hEDS and HSD patients, when given a list of 17 treatment modalities in a…
News
A novel minimally invasive surgical procedure called percutaneous transhepatic coil embolization was successfully used to treat an aneurysm in a 17-year-old boy with vascular Ehlers–Danlos syndrome (vEDS), a new study reports. “This case highlights the importance of an integrative multidisciplinary approach in managing complex vascular emergencies and successfully demonstrates…
A possible link has been suggested between Ehlers-Danlos syndrome (EDS) and idiopathic intracranial hypertension (IIH), a condition in which pressure builds up in the skull without an obvious cause. In a case series, a team of U.S. researchers described three women with EDS who showed signs of elevated intracranial…
AÂ man with myopathic Ehlers-Danlos syndrome (mEDS) was able to retain motor function because of the interaction of two separate mutations in the COL12A1 gene, according to a case report. The man had brain issues as well: Chiari malformation type 1, a condition in which the cerebellum (a brain region…
A new smartphone app, called the Hypermobility Assessment Tool (HAT), may aid in earlier and more accurate screening for Ehlers-Danlos syndrome (EDS). Powered by artificial intelligence (AI), the app uses a smartphone camera to analyze how a person moves and identify hypermobile joints, a hallmark sign of EDS. Approved by…
Weight loss surgery, medically known as metabolic and bariatric surgery, or MBS, can be safely performed in people with hypermobile Ehlers-Danlos syndrome (hEDS), according to two U.S. researchers behind a new case report. The team detailed the case of a woman in California with hEDS who underwent two types…
A promising surgical technique involving a skin transplant followed by an application of “spray-on skin cells” may help wounds to heal in people with Ehlers-Danlos syndrome (EDS), according to a recent case report. The report is the first to document the use of this regenerative cell technology, typically used…
Hypermobile Ehlers-Danlos syndrome (EDS) is not just a problem of the connective tissue that provides structure to the body, but also involves changes in the immune response, which could provide opportunities to improve diagnosis and treatment, a study finds. “Our study provides strong evidence that immune dysregulation plays a…
Prolotherapy, a type of regenerative medicine, may be a promising option to treat sacroiliac joint instability in people with Ehlers-Danlos syndrome (EDS), according to a small study. Treatment reduced self-reported pain in the sacroiliac joint, where the spine meets the pelvis, and improved the functional outcomes of patients,…
Mutations in the B3GALT6 gene, a cause of spondylodysplastic Ehlers-Danlos syndrome (spEDS), disrupt the maturation of a type of collagen protein, undermining the structure and strength of connective tissue, according to a new study. These findings “may have a significant impact on the clinical expression of spEDS and advance…
Recent Posts
- Pelvic muscle, nerve dysfunction may drive urinary symptoms in hEDS July 24, 2026
- Study finds higher allergy rates in children with hypermobile EDS July 17, 2026
- Hypermobility signs common in women with pelvic pain, study finds July 10, 2026
- Signing off after 7 great years as an EDS columnist July 9, 2026
- Psychiatric drugs don’t affect heart rhythms in hEDS, study finds June 25, 2026
- hEDS patients report less pain with long-term medical cannabis use June 18, 2026
- I’m trying to be patient with my healing process under an unusually hot sun June 16, 2026
- hEDS study points to pain, movement fears as quality-of-life hurdles June 11, 2026
- Eating challenges common among women with self-reported EDS June 4, 2026
- I know my EDS, so advocating for myself after my injury was the right call June 2, 2026